elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26738671-E9762FCF-DDB9-4237-8C0E-92C2B3C51A12
Q26738671-E9762FCF-DDB9-4237-8C0E-92C2B3C51A12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738671-E9762FCF-DDB9-4237-8C0E-92C2B3C51A12
Melanoma immunotherapy dominates the field
P2860
Q26738671-E9762FCF-DDB9-4237-8C0E-92C2B3C51A12
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26738671-E9762FCF-DDB9-4237-8C0E-92C2B3C51A12
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
28cc61181b2f9a72d3f47c00e6efdc7e14373c59
P2860
Improved survival with vemurafenib in melanoma with BRAF V600E mutation